Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of ciprofol combined with alfentanil for painless gastroscopy
ChiCTR2300074791Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Feb 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofol and alfentanil in gastrointestinal conditions (4 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: First induction success rate. Started Feb 2023; status: recruiting.
02
Drugs
ciprofolalfentanil
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2300074791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074791.